61714-42-9 Usage
General Description
6-[(phenylsulphonyl)amino]hexanoic acid is a chemical compound with the molecular formula C13H19NO4S. It is an amino acid derivative and contains a hexanoic acid backbone with a phenylsulphonyl group attached to the amino group. 6-[(phenylsulphonyl)amino]hexanoic acid is often used as a building block in organic synthesis and pharmaceutical research. The phenylsulphonyl group provides a lipophilic character to the molecule, making it suitable for drug design and delivery applications. Additionally, the compound has potential applications in the treatment of various diseases and disorders due to its ability to interact with biological systems. Further research is being conducted to explore the full range of possible uses and properties of 6-[(phenylsulphonyl)amino]hexanoic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 61714-42-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,7,1 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 61714-42:
(7*6)+(6*1)+(5*7)+(4*1)+(3*4)+(2*4)+(1*2)=109
109 % 10 = 9
So 61714-42-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO4S/c14-12(15)9-5-2-6-10-13-18(16,17)11-7-3-1-4-8-11/h1,3-4,7-8,13H,2,5-6,9-10H2,(H,14,15)
61714-42-9Relevant articles and documents
PROTEASOME INHIBITORS AND METHODS OF USING THE SAME
-
Page/Page column 212-213, (2008/06/13)
The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.
Inhibitors of histone deacetylase
-
, (2008/06/13)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
SYNTHESIS OF ALIPHATIC AMINES RELATED TO MONODANSYLCADAVERINE VIA THE OXIDATIVE REARRANGEMENT OF ALIPHATIC AMIDES WITH PHENYL IODOSYL BIS(TRIFLUOROACETATE)
Pavlidis, V. H.,Chan, E. D.,Pennington, L.,McParland, M.,Whitehead, M.
, p. 1615 - 1624 (2007/10/02)
A series of aliphatic primary amides have been oxidatively rearranged to primary amines with phenyl iodosyl(trifluoroacetate).Sulfonamide groups on the substrates have not been affected.
